Senior insider sale
Chief Technology Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$183.8K
6.37K shares
What this filing means
HARMON CYRUS plans to sell 6.37K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $183.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2026ACC: 0001959173-26-000308
DirectorOfficer· Chief Technology Officer
Since Nov 2020
6.37K
Shares to sell
$183.8K
Approx. market value
3.49K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founder Shares
Compensation
3/20/2007
3.49KTotal acquired3.49K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/20/2007 | Founder Shares Compensation | 3.49K | — |
| Total | 3.49K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.88K
Market value
$82.2K
12/22/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.49K
Market value
$101.6K
1/14/2026
Total
Units
6.37K
Value
$183.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/22/2025 | 2.88K | $82.2K | — | Completed |
| Planned — Approximate Date | ||||
1/14/2026 | 3.49K | $101.6K | NASDAQ | Planned |
| Total | 6.37K | $183.8K | ||